tirzepatide for heart failure 💊 New research in obesity & The SUMMIT study looked at tirzepatide, a once-weekly injection, in people with both obesity and heart failure with preserved ejection fraction (HFpEF). Over 52 AHA 2024: Tirzepatide Lowers Risk

Women of childbearing age need specific counseling

Methods This observational pre-post study used Optums de-identified Market Clarity Data from January 1, 2007, to June 30, 2024

In addition to demonstrating the noninferiority of insulin glargine U-300 to insulin degludec U-100 with respect to its primary and main secondary endpoints, InRange was the first large randomized controlled trial to use CGM-based TIR as a primary efficacy endpoint, which may herald a shift toward incorporating CGM-based metrics into clinical trials

A phase 2 study to assess the immunomodulatory capacity of a lecithin-based delivery system of curcumin in endometrial cancer

This gut hormones role is to help regulate blood sugar after a meal